» Articles » PMID: 2664520

Early Metabolic Defects in Persons at Increased Risk for Non-insulin-dependent Diabetes Mellitus

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1989 Aug 10
PMID 2664520
Citations 188
Authors
Affiliations
Soon will be listed here.
Abstract

To identify early metabolic abnormalities in non-insulin-dependent diabetes mellitus (NIDDM), we measured sensitivity to insulin and insulin secretion in 26 first-degree relatives of patients with NIDDM and compared these subjects both with 14 healthy control subjects with no family history of NIDDM and with 19 patients with NIDDM. The euglycemic insulin-clamp technique, indirect calorimetry, and infusion of [3-3H]glucose were used to assess insulin sensitivity. Total-body glucose metabolism was impaired in the first-degree relatives as compared with the controls (P less than 0.01). The defect in glucose metabolism was almost completely accounted for by a defect in nonoxidative glucose metabolism (primarily the storage of glucose as glycogen). The relatives with normal rates of metabolism (mean +/- SEM, 1.81 +/- 0.27 mg per kilogram of body weight per minute) and impaired rates (1.40 +/- 0.22 mg per kilogram per minute) in oral glucose-tolerance tests had the same degree of impairment in glucose storage as compared with healthy control subjects (3.76 +/- 0.55 mg per kilogram per minute; P less than 0.01 for both comparisons). During hyperglycemic clamping, first-phase insulin secretion was lacking in patients with NIDDM (P less than 0.01) and severely impaired in their relatives with impaired glucose tolerance (P less than 0.05) as compared with control subjects; insulin secretion was normal in the relatives with normal glucose tolerance. We conclude that impaired glucose metabolism is common in the first-degree relatives of patients with NIDDM, despite their normal results on oral glucose-tolerance tests. Both insulin resistance and impaired insulin secretion are necessary for the development of impaired glucose tolerance in these subjects.

Citing Articles

Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society.

Rodacki M, Zajdenverg L, da Silva Junior W, Giacaglia L, Negrato C, Cobas R Diabetol Metab Syndr. 2025; 17(1):78.

PMID: 40038723 PMC: 11881304. DOI: 10.1186/s13098-024-01572-w.


Multiomics profiling of DNA methylation, microRNA, and mRNA in skeletal muscle from monozygotic twin pairs discordant for type 2 diabetes identifies dysregulated genes controlling metabolism.

Ling C, Vavakova M, Mir B, Sall J, Perfilyev A, Martin M BMC Med. 2024; 22(1):572.

PMID: 39623445 PMC: 11613913. DOI: 10.1186/s12916-024-03789-y.


Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.

Makinen S, Sree S, Ala-Nisula T, Kultalahti H, Koivunen P, Koistinen H Diabetologia. 2024; 67(9):1943-1954.

PMID: 38814443 PMC: 11410918. DOI: 10.1007/s00125-024-06185-6.


Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model.

Hossain M, Roat R, Christopherson J, Free C, Ansarullah , James B Front Endocrinol (Lausanne). 2023; 14:1244688.

PMID: 38027148 PMC: 10646418. DOI: 10.3389/fendo.2023.1244688.


Molecular regulators of exercise-mediated insulin sensitivity in non-obese individuals.

Almuraikhy S, Doudin A, Domling A, Althani A, Elrayess M J Cell Mol Med. 2023; 28(1):e18015.

PMID: 37938877 PMC: 10805515. DOI: 10.1111/jcmm.18015.